A new study suggests that SARS-CoV-2, the virus that causes COVID-19, is most likely to target specific cells present in the nasal passages, lungs, and small intestine.
A new study by researchers from the Massachusetts Institute of Technology (MIT) and Harvard University, both in Cambridge, MA — alongside colleagues from other institutions — may have pinpointed the cells that SARS-CoV-2 primarily targets in the human body.
The study — the findings of which will soon appear in the journal Cell — built on existing investigations showing that SARS-CoV-2 uses two proteins that act as receptors to invade host cells and replicate.